Financial Gravity Asset Management, Inc. Sorrento Therapeutics, Inc. Transaction History
Financial Gravity Asset Management, Inc.
- $459 Billion
- Q1 2025
A detailed history of Financial Gravity Asset Management, Inc. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 18 shares of SRNE stock, worth $5. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$5% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SRNE
# of Institutions
13Shares Held
5.48MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Goodman Advisory Group, LLC102KShares$33,4960.28% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA14.9KShares$4,9210.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...